How Chinese companies list on Nasdaq.

By Priya Menon · 5 July 2026 · 8 min read

Chinese companies typically list on Nasdaq through an offshore holding company — often incorporated in the Cayman Islands — that owns or contractually controls the mainland business, audited to US standards. The listing must navigate US audit-inspection rules (the HFCAA) and China’s CSRC overseas-listing filing regime. This is a general map, not advice.

Why Chinese companies pursue a US listing

The appeal of a US listing is long-standing. The American markets are among the deepest and most liquid in the world, a Nasdaq listing is a globally recognised benchmark of scale and credibility, and public shares provide a tradable currency for acquisitions and for attracting and retaining talent through equity. For some companies, particularly in technology and consumer sectors, a US listing has historically offered a faster or more certain path than domestic listing queues, and access to investors familiar with high-growth models. None of this is one-directional: a US listing brings continuous disclosure, US-standard audits, governance obligations and cross-border approvals, and the balance between home-market and US listings shifts with policy and market conditions. Whether a US listing genuinely fits a particular company is a question for its board and its PRC and US advisers — our role is to explain the routes and coordinate the specialists. Our China market page sets out these considerations in more detail.

The offshore holding company and the VIE

A mainland Chinese operating company cannot usually list its domestic shares directly on Nasdaq. Instead, the group is typically restructured under an offshore holding company, most often incorporated in the Cayman Islands (BVI is also used at intermediate levels). It is this offshore holdco that lists in the United States; investors buy its shares, and the mainland business sits beneath it in the group. Building that structure requires home-market steps — outbound-investment and foreign-exchange approvals among them — and a clean chain of ownership from the listed entity down to the operations.

Where the business operates in a sector in which foreign ownership is restricted or prohibited, direct equity ownership by the offshore holdco may not be permitted. In those cases companies have historically used a variable interest entity (VIE) structure: rather than owning the operating company, the listed group controls it and consolidates its financial results through a web of contracts — typically covering economic benefits, control rights, and options over the equity. A VIE lets the offshore holdco report the operating business’s results while the licences and assets remain in domestic hands. It also introduces specific risks — the contracts must be enforceable, the arrangement must be disclosed fully to US investors, and policy toward VIEs can change. Whether a VIE is necessary or appropriate, and how it should be documented, is a matter for PRC counsel; the disclosure of its risks to US investors is a matter for US securities counsel.

HFCAA and PCAOB audit inspection

US-listed companies must be audited by a PCAOB-registered firm, and the Holding Foreign Companies Accountable Act (HFCAA) requires that the Public Company Accounting Oversight Board be able to inspect that firm’s audit work papers. For many years, access to the work papers of auditors based in mainland China and Hong Kong was constrained, which put Chinese issuers at risk of trading prohibitions if inspection could not be completed over consecutive years. Arrangements to permit inspection have since been reached, but the underlying requirement stands: the audit behind a China-to-US listing must be one the PCAOB can actually inspect, and issuers must plan on that basis. In practice this means engaging an audit firm that is PCAOB-registered and inspectable, and preparing financial statements to US GAAP or IFRS. Audit quality and inspectability are not box-ticking — they are central to whether the listing can be maintained.

CSRC overseas-listing filing rules

On the China side, the China Securities Regulatory Commission (CSRC) introduced overseas-listing filing rules that took effect in 2023. Broadly, domestic companies seeking to list abroad — whether directly or through an offshore structure such as the Cayman holdco described above — are required to make a filing with the CSRC and to provide information about the offering and the group. The regime is a filing and information framework layered on top of the sectoral, foreign-investment and foreign-exchange rules that already apply. It applies to indirect overseas listings, which captures the typical China-to-US structure, and it interacts with data-security and other reviews for companies of certain kinds. The practical point for a founder is that a US listing is no longer only a US-side project: the home-market filing must be planned from the outset, on a realistic timetable, and executed by qualified PRC counsel. We coordinate that work rather than perform it.

The reverse takeover route specifically

A Chinese company can reach a US listing either through a traditional IPO or through a reverse takeover (reverse merger) into an existing US-listed shell. In an RTO, the offshore holding company merges with a clean, already-reporting US shell; the Chinese group’s owners end up with the majority of the shares, and the operating business becomes the public company’s business. The attraction is the same as for any issuer — the vehicle already exists and already reports, so the path to trading is generally measured in months rather than the year or more a full IPO can take, with more control over valuation and timing.

What an RTO does not do is exempt a Chinese company from any of the above. The offshore structure still has to be built, the CSRC filing still has to be made, the audit still has to be PCAOB-inspectable, and the VIE risks (if any) still have to be disclosed. The reverse takeover changes the mechanism of becoming public; it does not change the structural and regulatory substance. It also raises its own risks — above all the quality of the shell — which we cover in our reverse takeover risks piece. Where the goal is a Nasdaq listing specifically, the company must also be able to meet Nasdaq’s quantitative and governance standards, whether it lists there directly or begins on the OTC Markets and uplists into a Nasdaq shell once it qualifies.

Key risks and considerations

A China-to-US listing sits at the intersection of two regulatory systems and several bodies of law, and it should be approached with that complexity in mind. The main considerations are the enforceability and disclosure of any VIE arrangement; the availability of a PCAOB-inspectable audit and the HFCAA implications if inspection lapses; the CSRC filing and any parallel data or sectoral reviews; foreign-exchange and outbound-investment approvals; and, throughout, full and accurate disclosure to US investors of the structure and its risks. Policy on both sides of this relationship evolves, and what is workable in one period may tighten in another. For that reason this article is deliberately general and educational: it is a map of the terrain, not a route for a specific company. The actual path must be designed and executed with qualified PRC counsel, US securities counsel, and a PCAOB-registered auditor, coordinated as one team. That coordination — making the home-market and US-side workstreams fit together on a sensible timetable — is where we add value.